Skandinaviska Enskilda Banken (SEB)’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-8,028
| Closed | -$1.97M | – | 928 |
|
2022
Q3 | $1.97M | Sell |
8,028
-4,684
| -37% | -$1.15M | 0.02% | 549 |
|
2022
Q2 | $3.15M | Buy |
12,712
+1,054
| +9% | +$261K | 0.02% | 463 |
|
2022
Q1 | $3.86M | Sell |
11,658
-1,301
| -10% | -$431K | 0.02% | 462 |
|
2021
Q4 | $4.69M | Sell |
12,959
-986
| -7% | -$357K | 0.02% | 433 |
|
2021
Q3 | $4.54M | Buy |
13,945
+856
| +7% | +$279K | 0.02% | 436 |
|
2021
Q2 | $4.09M | Buy |
13,089
+72
| +0.6% | +$22.5K | 0.03% | 464 |
|
2021
Q1 | $4.15M | Buy |
13,017
+925
| +8% | +$295K | 0.03% | 435 |
|
2020
Q4 | $3.92M | Sell |
12,092
-34,131
| -74% | -$11.1M | 0.03% | 432 |
|
2020
Q3 | $12.8M | Buy |
46,223
+5,192
| +13% | +$1.44M | 0.09% | 199 |
|
2020
Q2 | $9.91M | Buy |
41,031
+33,555
| +449% | +$8.11M | 0.08% | 228 |
|
2020
Q1 | $1.09M | Sell |
7,476
-1,446
| -16% | -$210K | 0.01% | 631 |
|
2019
Q4 | $1.52M | Buy |
8,922
+979
| +12% | +$167K | 0.01% | 625 |
|
2019
Q3 | $1.41M | Buy |
7,943
+1,263
| +19% | +$225K | 0.01% | 622 |
|
2019
Q2 | $1.74M | Sell |
6,680
-47,277
| -88% | -$12.3M | 0.02% | 555 |
|
2019
Q1 | $15.4M | Buy |
53,957
+40,367
| +297% | +$11.5M | 0.14% | 141 |
|
2018
Q4 | $4.42M | Buy |
13,590
+1,201
| +10% | +$390K | 0.04% | 295 |
|
2018
Q3 | $5.57M | Buy |
12,389
+6,200
| +100% | +$2.79M | 0.04% | 281 |
|
2018
Q2 | $2.53M | Buy |
+6,189
| New | +$2.53M | 0.02% | 383 |
|